Chlorpheniramine Maleate Market - Forecast (2022 - 2027)
Chlorpheniramine Maleate Market size is estimated to reach $924 million by 2027, growing at a CAGR of 4.4% during the forecast period 2022-2027. Chlorpheniramine Maleate is an antiallergic medicine utilized in the treatment of different allergic conditions. It offers alleviation from runny nose, sneezing, itching, and watery eyes. Chlorphenamine (CP, CPM), also termed chlorpheniramine, is an antihistamine utilized to treat the symptoms of allergic conditions like allergic rhinitis (hay fever). It is consumed by mouth. The medicine takes impacts within 6 hours and lasts for around a day. Piriton tablets and syrup include the active ingredient chlorphenamine maleate. Investigations have indicated that the three medications fexofenadine, chlorpheniramine maleate, and Betamethasone have similar levels of efficiency in curbing the symptoms of allergic rhinitis. The physical signs have been found to be enhanced better with chlorpheniramine than the other two medications. Antihistamines are...